宣泰医药：第二届董事会第二十三次会议决议公告

Group 1 - The core viewpoint of the article is that Xuantai Pharmaceutical has announced the approval of significant resolutions during its board meeting [2] Group 2 - The second session of the board's 23rd meeting reviewed and approved the proposals regarding the company and its summary [2]